Adrenal function of low-birthweight children

Ken Ong1

  • 1Department of Paediatrics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.

Endocrine Development
|February 22, 2005
PubMed

Insights

Low birthweight infants may experience altered adrenal hormone secretion, potentially increasing long-term risks for hypertension, cardiovascular disease, and metabolic syndrome. This highlights critical developmental programming effects.

Area of Science:

  • Endocrinology
  • Neonatal Medicine
  • Metabolic Health

Background:

  • Low birthweight infants face increased stress, necessitating adequate adrenal cortisol secretion for survival.
  • Transient cortisol insufficiency is common in early neonatal life for low birthweight infants, followed by normalization or elevation.
  • Early life stress and low birthweight may program long-term alterations in adrenal hormone production.

Purpose of the Study:

  • To investigate the long-term consequences of altered adrenal cortisol and androgen secretion in low birthweight survivors.
  • To explore the link between early life adrenal function programming and later-life metabolic and cardiovascular health.
  • To understand the role of adrenal hyperandrogenism in conditions like precocious pubarche and polycystic ovary syndrome.

Main Methods:

  • This study is a review and synthesis of existing research on neonatal stress, low birthweight, and adrenal function.
  • Analysis of hormonal profiles (cortisol and androgens) in low birthweight infants and long-term follow-up data.
  • Correlation of early life adrenal activity with later development of hypertension, cardiovascular disease, and metabolic syndrome markers.

Main Results:

  • Low birthweight and neonatal stress can lead to programming of higher cortisol secretion, potentially increasing later cardiovascular risk.
  • Increased adrenal androgen secretion in low birthweight infants is linked to hyperandrogenism and hyperinsulinemia.
  • Precocious pubarche in girls, a sign of adrenal hyperandrogenism, predicts polycystic ovary syndrome and metabolic disturbances.

Conclusions:

  • Long-term effects of low birthweight impact both adrenal cortisol and androgen secretion.
  • These hormonal changes contribute to an increased risk of developing metabolic syndrome later in life.
  • Early life programming of adrenal function in low birthweight infants has significant implications for adult health.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Anatomy of the Adrenal Glands01:17

Anatomy of the Adrenal Glands

The adrenal or supra-renal glands, situated above the kidneys and aligned with the twelfth rib, are paired pyramid-shaped structures crucial for the body's stress response. During stress, these glands secrete hormones vital for adaptive physiological reactions.
These glands possess a distinctive yellow tinge due to the stored cholesterol and fatty acids required for hormone synthesis. They are encased in a fibrous capsule and cushioned by fat.
The adrenal gland comprises two distinct regions...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...